Bio-Techne
Strategic Account Manager (Southeast)
Atlanta, GA | $123K - $161K
Qualifications
- Strong presentation skills, capable of effectively conveying ideas, scientific information, and economic data to clients in a clear and impactful manner
- Excellent communication skills with a strong commitment to follow-through
- Demonstrated ability to work inclusively and collaboratively, modeling behaviors that align with our organizational values
- Flexibility to accommodate occasional evening and weekend commitments
- Comfortable working on electronic devices for most of the workday, including typing tasks
- Proven ability to work effectively within cross-functional teams
- Possession of a valid driver's license
- Experience negotiating contracts with healthcare networks
- Ability to meet all healthcare facility access requirements, such as vaccinations and mask mandates
- Willingness to travel up to 50% of the time, including overnight and weekend trips
- Bachelor's degree in Sales, Marketing, Business Management, Science, or a related field
- Minimum of 6 years of sales experience in the healthcare sector, with a focus on urology, diagnostics, surgical, or pharmaceutical areas
- At least 2 years of experience in successfully navigating access and sales to Integrated Delivery Networks (IDNs), health systems, or academic institutions
Responsibilities
- They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses
- Bio-Techne’s Molecular Diagnostics Division, which is comprised of the Asuragen and Exosome Diagnostics brands, develops molecular assays and software solutions that broaden access to care, answer unmet needs, and improve health outcomes through novel reagent systems and an industry-leading exosome enrichment technology for liquid biopsies
- In this role, you will play a vital part in establishing and nurturing relationships with key clients, driving growth, and ensuring the successful integration of our innovative diagnostics solutions
- Lead the execution of strategic initiatives to foster collaborative relationships with Integrated Delivery Networks (IDNs), health systems, and academic institutions
- The goal is to map out current prostate cancer treatment pathway and promote the adoption of Exosome Dx solutions for improved clinical decision-making and increased market share
- Collaborate with internal teams and other market stakeholders to implement strategic plans aligned with specific IDNs, contributing to improved patient outcomes and increased share
- Build relationships with key stakeholders in c-suite, committees, urology departments in the healthcare system to gain insights into system needs and unmet patient requirements
- Educate urologists and stakeholder groups about Exosome Dx products, enabling informed treatment decisions and protocol changes
- Use data to track progress against business plans and adapt strategies as needed
- Ensure the execution of tactics to achieve business goals, coordinating with cross-functional stakeholders
- Uphold ethical and professional standards consistent with Exosome Dx guidelines and policies
- Uphold company mission and values through accountability, innovation, integrity, quality, and teamwork
- Maintain regular and reliable attendance
Benefits
- Salary Range: Undisclosed
- Travel Percentage: Up to 50%
- Bio-Techne provides a competitive salary, medical, dental, disability and life insurance, a 401(k) plan with company matching, an employee bonus plan, and a tuition reimbursement plan
- Additional components of compensation include stock option grants and an annual bonus plan
- 1,001-5,000 employees
- Biotechnology, Pharmaceuticals, Medical Devices, Diagnostics, Healthcare Equipment & Supplies, Biopharmaceuticals, Research Products, Medical Diagnostics & Research, Life Sciences Tools & Services
- Public Company
- Founded: 1981
- Minneapolis, Minnesota
Company information
Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workflow solutions including T-Cell activation technologies. Bio-Techne’s portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name, that offer researchers efficient and streamlined options for automated Western blot and multiplexed ELISA workflow. These reagent and protein analysis solutions are sold to biomedical researchers, as well as clinical research laboratories, and constitute the Protein Sciences Segment. Bio-Techne also develops and manufactures diagnostic products including FDA-regulated controls, calibrators, blood gas and clinical chemistry controls, and other reagents for OEM and clinical customers. Bio-Techne’s genomic tools include advanced tissue-based in situ hybridization assays (ISH) for research and clinical use, sold under the ACD brand, as well as a portfolio of clinical molecular diagnostic oncology assays including the ExoDx®Prostate (IntelliScore) test (EPI) for prostate cancer diagnosis. These diagnostic and genomic products comprise Bio-Techne’s Diagnostics and Genomics Segment. Bio-Techne products are integral components of scientific investigations into biological processes and molecular diagnostics, revealing the nature, diagnosis, etiology and progression of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $714 million in net sales in fiscal 2019 and has over 2,200 employees worldwide.
